November 15, 2011 – Abbott announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
November 15, 2011 — Results of ADAPT-DES (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents) were ...
November 15, 2011 – Results from the PROFI study indicate that the use of a proximal balloon occlusion in carotid artery ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
November 15, 2011 — Researchers have found polymer-free amphilimus-eluting stents in de novo coronary artery lesions ...
November 15, 2011 — A randomized clinical trial examining angioplasty approaches in patients with ST elevation acute ...
November 15, 2011 — The ADVISE clinical trial concluded that a new measure of stenosis severity — instantaneous wave ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
November 15, 2011 — A new clinical trial is testing the efficacy of rotational atherectomy (or rotablation, a process of ...
November 15, 2011 — A clinical trial has shown a drug-eluting stent (DES) with a bioabsorbable polymer has comparable ...
November 14, 2011 — A clinical trial of patients with restenosis in drug-eluting stents (DES) in native coronary ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
November 14, 2011 – Boston Scientific welcomed positive outcomes from the COBRA clinical trial, which evaluated post ...
November 14, 2011 – Medrad Inc. announced that five-year data from the THUNDER trial [1] demonstrated a 59 percent ...
November 14, 2011 – OrbusNeich announced the introduction of the Combo dual therapy stent during a breakfast symposium ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
November 14, 2011 – The TWENTE clinical trial, which compared Resolute versus Xience V drug-eluting stents in a real ...
November 11, 2011 – Boston Scientific reported results from the EVOLVE first human use trial demonstrating the non ...
November 11, 2011 – Biosensors International Group announced two-year results from the BioFreedom first-in-human trial ...